Dr. Feldmann conducts research on Ebola and other hemorrhagic fever viruses at NIH's National Institute of Allergy and Infectious Diseases (NIAID). Among other suggestions, he recommends that medical and public health staff in and near locations known to be endemic for Ebola be trained to assess infection risks and diagnose disease. Enhancing the capabilities of local laboratory workers would make test results available more rapidly by eliminating the need to ship samples to distant reference laboratories.
Dr. Feldmann and his NIAID colleague David Safronetz, Ph.D., explored this regional diagnostic approach while working with Malian health researchers and officials in April, after the nation reported 12 suspected Ebola cases. The NIAID group worked at the International Center for Excellence in Research, a partnership between NIAID and Mali's University of Bamako, where they observed isolation procedures and showed local physicians how to handle Ebola specimens and test for disease. All of the suspected cases in Mali tested negative.
H. Feldmann. EbolaA Surprise in West Africa? New England Journal of Medicine
DOI: 10.1056/NEJMp1405314 (2014).
NIAID Director Anthony S. Fauci, M.D., is available for interviews. Heinz Feldmann, M.D., Ph.D., an expert on Ebola virus and chief of NIAID's Laboratory of Virology, also is available.